Clinical Chemistry Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 46: 1686-1688, 2000;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (22)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tan, Y.
Right arrow Articles by Hoffman, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tan, Y.
Right arrow Articles by Hoffman, R. M.
Related Collections
Right arrow Endocrinology and Metabolism
Right arrow Automation and Analytical Techniques
(Clinical Chemistry. 2000;46:1686-1688.)
© 2000 American Association for Clinical Chemistry, Inc.


Technical Briefs

Total-Homocysteine Enzymatic Assay,

Yuying Tan1, Li Tang1, Xinghua Sun1, Nan Zhang1, Qinghong Han1, Mingxu Xu1, Eugene Baranov1, Xuezhong Tan1, Xiuying Tan1, Babak Rashidi1, Zili An1, Andrew W. Perry1 and Robert M. Hoffmana,1

1 A/C Diagnostics, LLC, and AntiCancer, Inc., 7917 Ostrow St., San Diego, CA 92111
a author for correspondence: fax 858-268-4175, e-mail all@anticancer.com

McCully (1) in 1969 first observed that plasma hyperhomocysteinemia was involved in the pathogenesis of arteriosclerosis. More studies have reported that total serum or plasma homocysteine (tHCY) is an independent risk factor for cardiovascular diseases, including arteriosclerosis, coronary artery disease, cerebrovascular disease, and myocardial infarction (2)(3)(4)(5)(6)(7). Furthermore, plasma tHCY is a strong predictor of mortality in patients with existing coronary artery disease (8).

A major basis for hyperhomocysteinemia is insufficient intake of vitamins B6, B12, and folic acid, which are necessary for homocysteine metabolism and which lower the risk for homocysteine-associated diseases (9)(10)(11). Homocystinuria can result from inborn errors, such as deficiencies in the enzymes cystathionine ß-synthase, methionine synthase, and methylenetetrahydrofolate reductase (12). These patients have premature vascular disease, ~50% of untreated patients have thromboembolic events, and the mortality rate is ~20% before the age of 30 (12).

Many methods have been developed to measure tHCY, such as the tHCY enzyme conversion immunoassay designed for the Abbott IMx analyzer (13), the microtiter-plate tHCY enzymatic immunoassay kit (14), and HPLC (15)(16)(17). However, these methods are relatively complex and require highly specialized equipment.

To meet the need for a widely available homocysteine assay, we have developed and describe here a simple single-enzyme tHCY assay based on a highly specific homocysteine {alpha},{gamma}-lyase (rHCYase) (18).

L-Homocystine, L-cysteine (L-CYS), L-methionine (L-MET), dithiothreitol (DTT), Triton X-100, citric acid, potassium ferricyanide, and other common reagents for the tHCY enzymatic assay were obtained from Sigma. 4-Fluoro-7-sulfobenzofurazan ammonium salt was obtained from Wako Fine Chemicals, and N,N-dibutylaniline was obtained from . . . [Full Text of this Article]


Acknowledgments


References




The following articles in journals at HighWire Press have cited this article:


Home page
Annals of Clinical & Laboratory ScienceHome page
E.-C. Chan, P.-Y. Chang, T.-L. Wu, and J. T. Wu
Enzymatic Assay of Homocysteine on Microtiter Plates or a TECAN Analyzer Using Crude Lysate Containing Recombinant Methionine {gamma}-Lyase
Ann. Clin. Lab. Sci., April 1, 2005; 35(2): 155 - 160.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
Q. Han, X. Sun, M. Xu, N. Zhang, L. Tang, Y. Tan, and R. M. Hoffman
3-Deazaadenosine, a Stabilizer of Whole-Blood Homocysteine Content, Does Not Interfere with the Single-Enzyme Homocysteine Assay while Totally Inhibiting the Enzyme Conversion Homocysteine Immunoassay
Clin. Chem., September 1, 2004; 50(9): 1703 - 1704.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
Q. Han, M. Xu, L. Tang, X. Sun, N. Zhang, X. Tan, X. Tan, Y. Tan, and R. M. Hoffman
Homogeneous Enzymatic Colorimetric Assay for Total Cysteine
Clin. Chem., July 1, 2004; 50(7): 1229 - 1231.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
Y. Tan, X. Sun, L. Tang, N. Zhang, Q. Han, M. Xu, X. Tan, X. Tan, and R. M. Hoffman
Automated Enzymatic Assay for Homocysteine
Clin. Chem., June 1, 2003; 49(6): 1029 - 1030.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
Q. Han, M. Xu, L. Tang, X. Tan, X. Tan, Y. Tan, and R. M. Hoffman
Homogeneous, Nonradioactive, Enzymatic Assay for Plasma Pyridoxal 5-Phosphate
Clin. Chem., September 1, 2002; 48(9): 1560 - 1564.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
N. Matsuyama, M. Yamaguchi, M. Toyosato, M. Takayama, and K. Mizuno
New Enzymatic Colorimetric Assay for Total Homocysteine
Clin. Chem., December 1, 2001; 47(12): 2155 - 2156.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American Association for Clinical Chemistry.